About the Company
eton pharmaceuticals, inc. is a deer park, illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the u.s. food and drug administration’s 505(b)(2) regulatory pathway. our mission is to advance healthcare through the introduction of innovative medicines that are affordable and available to all patients.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ETON News
Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...
Revenue Growth: Q4 product sales and royalty revenue surged by 109% year-over-year to $7.3 million. Positive Cash Flow: ETON ...
Eton Pharmaceuticals Inc ETON
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Eton Pharma Buys U.S. Rights To PKU GOLIKE From Relief Therapeutics
(RTTNews) - Eton Pharmaceuticals Inc (ETON) said that it has acquired U.S. rights to PKU GOLIKE from Relief Therapeutics Holding SA. PKU is a rare inherited disorder caused by a defect in the ...
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
GENEVA, SWITZERLAND / ACCESSWIRE / /RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the ...
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
For more detailed information, please see full Prescribing Information for more information.To report a suspected adverse event related to Nitisinone, contact Eton Pharmaceuticals, Inc. at ...
Eton Pharma Buys U.S. Rights To PKU GOLIKE From Relief Therapeutics
Eton Pharmaceuticals Inc (ETON) said that it has acquired U.S. rights to PKU GOLIKE from Relief Therapeutics Holding SA. PKU is a ...
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.04 per share a year ago.
Eton Pharmaceuticals Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...